Immediate Impact

1 by Nobel laureates 2 from Science/Nature 73 standout
Sub-graph 1 of 23

Citing Papers

Targeting mitophagy in neurodegenerative diseases
2025 Standout
Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
2025 StandoutNature
1 intermediate paper

Works of Sarah Moll being referenced

A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease
2023
Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study
2020

Author Peers

Author Last Decade Papers Cites
Sarah Moll 182 24 5 122 65 6 302
A. Mastrogiacomo 214 23 85 86 9 366
Carolyn V. Taylor 123 8 1 60 84 7 355
Clemens Bartz 202 3 2 130 117 9 360
Michael Lammiman 215 3 1 148 67 6 325
A.M.A. Lachmeijer 148 14 147 71 7 314
Jessica E. Davies 153 4 13 72 119 7 328
Meagan Haynes 82 10 3 99 21 9 324
Kanako Pryor‐Koishi 234 4 4 189 104 9 364
Po Jen Chiang 141 5 2 127 108 8 315
Michael Zinger 64 6 58 44 11 370

All Works

Loading papers...

Rankless by CCL
2026